Pure Global

FTD URETHRITIS BASIC - COFEPRIS Registration 279R2019 SSA

Access comprehensive regulatory information for FTD URETHRITIS BASIC (FTD URETHRITIS BASIC) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 279R2019 SSA and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.. The device was registered on February 14, 2019.

This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.

Free Database
Powered by Pure Global AI
COFEPRIS Official Data
Clase II
279R2019 SSA
FTD URETHRITIS BASIC
COFEPRIS Analysis ID: 279R2019 SSA
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Product Use / Uso del Producto
Spanish

FTD URETHRITIS BASIC ES UNA PRUEBA IN VITRO PARA LA DETECCIร“N DE รCIDOS NUCLEICOS EN MUESTRAS DE ORINA, GENITALES E HISOPOS RECTALES DE ORIGEN HUMANO, COMO UNA AYUDA PARA LA EVALUACIร“N DE INFECCIONES POR CHLAMYDIA TRACHOMATIS, NEISSERIA GONORRHOEAE Y MYCO

English

FTD URETHRITIS BASIC IS AN IN VITRO TEST FOR THE DETECTION OF NUCLEIC ACIDS IN URINE, GENITAL, AND RECTAL SWABS OF HUMAN ORIGIN, AS AN AID TO THE EVALUATION OF CHLAMYDIA TRACHOMATIS, NEISSERIA GONORRHOEAE AND MYCO INFECTIONS.

Device Classification
Risk Class / Clase de Riesgo
Clase II
Product Type (Spanish)
III. AGENTES DE DIAGNร“STICO
Product Type (English)
III. DIAGNOSTIC AGENTS
Trade Name (Spanish)
ENSAYO PARA LA DETERMINACIร“N DE รCIDOS NUCLEICOS
Trade Name (English)
NUCLEIC ACID ASSAY
Registration Information
Analysis ID
279R2019 SSA
Registration Date
February 14, 2019
Manufacturer / Fabricante
Name (English)
SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.